Contact us  Chinese
Shanghai Newsummit Biopharma Co.Ltd
business solutions
core business

Core Business Model

Key Products

core competitive advantages

Core Competitive Advantages
& Industry Status

Newsummit CRO Service Network

Prime Minister Li’s visit to Britain to witness the signing in 2014

In mid-June 2014,during Prime Minister Li’s visit to Britain with the promotion of Commerce Department,Shanghai Newsummit Biopharma Group Co,Ltd,MRCT,Dynasty,Oncopharm and Medannex Limited signed the contract at Sino-British economic and trade forum witnessed by both leaders on 17th June.The contract is about the agreement on the transfer and cooperation of antibody drug between MRCT and Zhangjiang Bio-pharmaceutical international incubation platform,the agreement on Sino-British Dynasty innovative drug development and the agreement on Sino-British innovative development.


Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center